Low-estrogen receptor-positive breast cancer: The impact of tissue sampling, choiceof antibody, and molecular subtyping

Journal of Clinical Oncology

Volumn 30, Issue 23, 2012, Pages 2929-2930

  Rakha, Emad A ^a,b   Lee, Andrew H S ^a,b   Roberts, Joseph ^a,b   Villena Salinas, Nadia M ^a,b   Hodi, Zsolt ^a,b   Ellis, Ian O ^a,b   Reis Filho, Jorge S ^c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; ESTROGEN RECEPTOR;

BREAST CANCER; CANCER CLASSIFICATION; CANCER SURGERY; FALSE POSITIVE RESULT; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MICROARRAY ANALYSIS; PRIORITY JOURNAL;

BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; RNA, MESSENGER;

EID: 84865101603     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.2831     Document Type: Letter

References (17)

1. Iwamoto T, Booser D, Valero V, et al: Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry. J Clin Oncol 30:729-734, 2012
2. Hodi Z, Chakrabarti J, Lee AH, et al: The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast. J Clin Pathol 60:299-302, 2007
3. Arnedos M, Nerurkar A, Osin P, et al: Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 20:1948-1952, 2009
4. Douglas-Jones AG, Collett N, Morgan JM, et al: Comparison of core oestrogen receptor (ER) assay with excised tumour: Intratumoral distribution of ER in breast carcinoma. J Clin Pathol 54:951-955, 2001
5. Park SY, Kim KS, Lee TG, et al: The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer. Am J Surg 197:266-269, 2009
6. Usami S, Moriya T, Amari M, et al: Reliability of prognostic factors in breast carcinoma determined by core needle biopsy. Jpn J Clin Oncol 37:250-255, 2007
7. Rakha EA, Ellis IO: An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol 60:1300-1306, 2007
8. Al Sarakbi W, Salhab M, Thomas V, et al: Is preoperative core biopsy accurate in determining the hormone receptor status in women with invasive breast cancer? Int Semin Surg Oncol 2:15, 2005
9. Khoury T, Zakharia Y, Tan W, et al: Breast hormonal receptors test should be repeated on excisional biopsy after negative core needle biopsy. Breast J 17:180-186, 2011
10. Tamaki K, Sasano H, Ishida T, et al: Comparison of core needle biopsy (CNB) and surgical specimens for accurate preoperative evaluation of ER, PgR and HER2 status of breast cancer patients. Cancer Sci 101:2074-2079, 2010
11. Cheang MC, Treaba DO, Speers CH, et al: Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol 24:5637-5644, 2006
12. Kaplan PA, Frazier SR, Loy TS, et al: 1D5 and 6F11: An immunohistochemical comparison of two monoclonal antibodies for the evaluation of estrogen receptor status in primary breast carcinoma. Am J Clin Pathol 123:276-280, 2005
13. Gomez-Fernandez C, Mejias A, Walker G, et al: Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: The antibody factor. Appl Immunohistochem Mol Morphol 18:137-141, 2010
14. Nielsen TO, Parker JS, Leung S, et al: A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res 16:5222-5232, 2010
15. Stomper PC, Stewart CC, Stoler DL: Stereotactic core biopsy breast and blood cell by-products: A source of material for molecular genetics research - Initial experience. Radiology 218:881-885, 2001
16. Gerlinger M, Rowan AJ, Horswell S, et al: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883-892, 2012
17. Hammond ME, Hayes DF, Dowsett M, et al: American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 28:2784-2795, 2010